secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evolus, Inc. (EOLS)
CIK:        0001570562
Form:       8-K
Filed at:   2022-01-26T23:59:59+00:00
Accession:  0001570562-22-000015
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Evolus reports Q4 preliminary revenue $34.7M (+68% YoY), guides 2022 revenue $143-150M
--------------------------------------------------------------------------------

- Q4 2021 preliminary net revenue $34.7M, up 68% YoY; full-year 2021 revenue $99.7M, up 76% YoY.
- Cash position $146.3M at Dec 31, 2021; expects sufficient funding through cash flow breakeven.
- 2022 net revenue guidance $143-150M (43-50% growth); adjusted gross margin 58-61% full year, improving to 68-71% in Q4.
- Plans to initiate Phase 2 'extra strength' Jeuveau trial in Q1 2022; European Nuceiva launch in Q3 2022.
- Added 1,400+ new accounts in 2021; consumer loyalty program reached 270,000+.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1570562/000157056222000015/0001570562-22-000015-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1570562/000157056222000015/eols-20220126.htm
  HTML page:      https://secwatch.observer/filing/0001570562-22-000015

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer